Comparative evaluation of the efficacy of customized maxillary oral appliance with mandibular advancement appliance as a treatment modality for moderate obstructive sleep apnea patients-a randomized controlled trial.
Apnea/hypopnea index
Customized or custom-made maxillary oral appliance
Mandibular advancement splint
Obstructive sleep apnea disorder
Polysomnography
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
01 Feb 2023
01 Feb 2023
Historique:
received:
17
05
2022
accepted:
27
12
2022
entrez:
2
2
2023
pubmed:
3
2
2023
medline:
4
2
2023
Statut:
epublish
Résumé
Obstructive sleep apnea (OSA) is quite common among the adult population, according to recent epidemiological studies. The most frequently suggested alternate treatment for mild to moderate OSA is oral appliances (OA). The purpose of the present study was to assess as well as compare the effectiveness of custom-made maxillary oral appliances against mandibular advancement appliances in the care of individuals suffering from moderate obstructive sleep apnea. A prospective interventional research was carried out with 40 participants. Polysomnography (PSG) was done and the participants with an apnea-hypopnea index (AHI) >15-30 were involved in the research. Study participants were randomly split up into two test groups: group I was the "Control Group" (group treated with a mandibular advancement device (MAD), n=20), while group II was exposed to a "customized maxillary oral appliance" (CMOA, n=20). Both groups had reference measures for AHI, blood oxygen saturation (SpO2), oro-nasal airflow via respiratory disturbance index (RDI), and the Epworth Sleepiness Scale (ESS). Appliances were fabricated and delivered to the respective study group participants. PSG was again conducted after a period of 1 and 3 months of appliance delivery and re-evaluation was done for all the parameters and was compared with reference measurements. The facts were analyzed using descriptive and analytical statistical methods. The statistical program utilized in the study was "SPSS (Statistical Package for Social Sciences) Version 20.1." After 1 and 3 months, the statistical significance between the two study groups was assessed at P<0.05. The analysis of mean AHI, SPO2, RDI, and ESS for both test groups manifested statistically significant measures (P<0.001). The study results revealed a statistically significant depletion in mean AHI scores, improvement in mean SPO2 scores, and reduction in mean RDI scores and ESS scores when compared with reference measurements to 1 month, 1 to 3 months, and between reference measurements and 3 months. The CMOA was effective in managing moderate OSA and has great therapeutic potential. It can be an option for the MAD for treating patients suffering from moderate obstructive sleep apnea. The study was registered under Clinical Trials Registry-India and the registration number is CTRI/2020/07/026936 . Registered on 31 July 2020.
Sections du résumé
BACKGROUND
BACKGROUND
Obstructive sleep apnea (OSA) is quite common among the adult population, according to recent epidemiological studies. The most frequently suggested alternate treatment for mild to moderate OSA is oral appliances (OA). The purpose of the present study was to assess as well as compare the effectiveness of custom-made maxillary oral appliances against mandibular advancement appliances in the care of individuals suffering from moderate obstructive sleep apnea.
METHODS
METHODS
A prospective interventional research was carried out with 40 participants. Polysomnography (PSG) was done and the participants with an apnea-hypopnea index (AHI) >15-30 were involved in the research. Study participants were randomly split up into two test groups: group I was the "Control Group" (group treated with a mandibular advancement device (MAD), n=20), while group II was exposed to a "customized maxillary oral appliance" (CMOA, n=20). Both groups had reference measures for AHI, blood oxygen saturation (SpO2), oro-nasal airflow via respiratory disturbance index (RDI), and the Epworth Sleepiness Scale (ESS). Appliances were fabricated and delivered to the respective study group participants. PSG was again conducted after a period of 1 and 3 months of appliance delivery and re-evaluation was done for all the parameters and was compared with reference measurements. The facts were analyzed using descriptive and analytical statistical methods. The statistical program utilized in the study was "SPSS (Statistical Package for Social Sciences) Version 20.1." After 1 and 3 months, the statistical significance between the two study groups was assessed at P<0.05.
RESULTS
RESULTS
The analysis of mean AHI, SPO2, RDI, and ESS for both test groups manifested statistically significant measures (P<0.001). The study results revealed a statistically significant depletion in mean AHI scores, improvement in mean SPO2 scores, and reduction in mean RDI scores and ESS scores when compared with reference measurements to 1 month, 1 to 3 months, and between reference measurements and 3 months.
CONCLUSION
CONCLUSIONS
The CMOA was effective in managing moderate OSA and has great therapeutic potential. It can be an option for the MAD for treating patients suffering from moderate obstructive sleep apnea.
TRIAL REGISTRATION
BACKGROUND
The study was registered under Clinical Trials Registry-India and the registration number is CTRI/2020/07/026936 . Registered on 31 July 2020.
Identifiants
pubmed: 36726182
doi: 10.1186/s13063-022-07054-6
pii: 10.1186/s13063-022-07054-6
pmc: PMC9890424
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
73Informations de copyright
© 2023. The Author(s).
Références
J Pharm Bioallied Sci. 2017 Nov;9(Suppl 1):S26-S28
pubmed: 29284930
Eur J Orthod. 2005 Feb;27(1):82-90
pubmed: 15743867
J Indian Prosthodont Soc. 2014 Dec;14(Suppl 1):255-9
pubmed: 26199526
Sleep Breath. 2005 Mar;9(1):20-5
pubmed: 15785917
Cranio. 2013 Oct;31(4):246-51
pubmed: 24308097
J Clin Sleep Med. 2019 Jul 15;15(7):979-983
pubmed: 31383235
Sleep Med. 2009 Mar;10(3):329-36
pubmed: 18583187
Sleep Breath. 2015 Mar;19(1):403-5
pubmed: 24788696
J Clin Sleep Med. 2018 May 15;14(5):711-712
pubmed: 29734996
Sleep Sci. 2018 Mar-Apr;11(2):118-122
pubmed: 30083300
Respirology. 2017 Nov;22(8):1500-1507
pubmed: 28901030
J Indian Prosthodont Soc. 2010 Mar;10(1):57-63
pubmed: 23204723
J Indian Prosthodont Soc. 2019 Jan-Mar;19(1):66-73
pubmed: 30745756
Am J Orthod Dentofacial Orthop. 1997 May;111(5):562-70
pubmed: 9155816
Sleep Breath. 2010 Feb;14(1):81-5
pubmed: 19554358
J Indian Prosthodont Soc. 2020 Oct-Dec;20(4):335-337
pubmed: 33487959
Cranio. 2019 Nov;37(6):347-364
pubmed: 29793390
Eur J Oral Sci. 2002 Apr;110(2):99-105
pubmed: 12013569
Turk Arch Otorhinolaryngol. 2018 Mar;56(1):1-6
pubmed: 29988275
Clin Oral Investig. 2012 Jun;16(3):689-97
pubmed: 21538074
J Clin Sleep Med. 2016 Sep 15;12(9):1209-10
pubmed: 27568904
J Clin Sleep Med. 2014 Feb 15;10(2):215-27
pubmed: 24533007
Cranio. 2021 Nov;39(6):472-483
pubmed: 31588866
Respir Res. 2021 Jan 15;22(1):17
pubmed: 33451313
J Clin Sleep Med. 2018 May 15;14(5):791-795
pubmed: 29734985
J Thorac Dis. 2018 Jan;10(Suppl 1):S48-S56
pubmed: 29445528
Trials. 2022 Feb 16;23(1):159
pubmed: 35172870
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Respir Med. 2019 Jul - Aug;154:127-132
pubmed: 31252205
Eur Respir J. 2004 Dec;24(6):987-93
pubmed: 15572543
J Family Med Prim Care. 2021 Sep;10(9):3172-3175
pubmed: 34760725
Southwest J Pulm Crit Care. 2014;9(1):44-56
pubmed: 25232509
Ann Biomed Eng. 2012 Aug;40(8):1825-34
pubmed: 22374322
Eur Respir Rev. 2019 Jun 26;28(152):
pubmed: 31243095
J Indian Prosthodont Soc. 2015 Oct-Dec;15(4):331-6
pubmed: 26929536
ERJ Open Res. 2020 Jun 08;6(2):
pubmed: 32537464
Am J Respir Crit Care Med. 2002 Aug 1;166(3):274-8
pubmed: 12153957
Sleep Breath. 2018 Sep;22(3):555-568
pubmed: 29129030